Cargando…
Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
BACKGROUND: Nasopharyngeal carcinoma (NPC), especially the nonkeratinizing type, is a malignant tumor primarily occurring in southern China and Southeast Asia. Chemotherapy (CT) and combined radiotherapy (RT) is used to treat NPC. However, the mortality rate is high in recurrent and metastatic NPC....
Autores principales: | Feng, Ling, Xu, Shengen, Li, Xiaochen, Sun, Xingwang, Long, Wenbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940331/ https://www.ncbi.nlm.nih.gov/pubmed/36803974 http://dx.doi.org/10.1186/s12885-023-10629-4 |
Ejemplares similares
-
Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
por: Ling, Feng, et al.
Publicado: (2023) -
High-Expression of Cytoplasmic Poly (A) Binding Protein 1 (PABPC1) as a Prognostic Biomarker for Early-Stage Esophageal Squamous Cell Carcinoma
por: Pu, Jiangtao, et al.
Publicado: (2021) -
Targeting of the cytosolic poly(A) binding protein PABPC1 to mitochondria causes mitochondrial translation inhibition
por: Wydro, Mateusz, et al.
Publicado: (2010) -
Poly(A) tail length regulates PABPC1 expression to tune translation in the heart
por: Chorghade, Sandip, et al.
Publicado: (2017) -
Functional compensation for the loss of testis-specific poly(A)-binding protein, PABPC2, during mouse spermatogenesis
por: KASHIWABARA, Shin-ichi, et al.
Publicado: (2016)